Edition:
United States

Advisory Board Co (ABCO.O)

ABCO.O on Nasdaq

51.20USD
23 Jun 2017
Change (% chg)

$0.15 (+0.29%)
Prev Close
$51.05
Open
$50.95
Day's High
$51.45
Day's Low
$50.85
Volume
290,963
Avg. Vol
489,601
52-wk High
$54.50
52-wk Low
$24.85

ABCO.O

Chart for ABCO.O

About

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research,... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $2,071.80
Shares Outstanding(Mil.): 40.58
Dividend: --
Yield (%): --

Financials

  ABCO.O Industry Sector
P/E (TTM): 20.60 25.77 22.84
EPS (TTM): 2.48 -- --
ROI: 2.52 8.97 6.45
ROE: 20.34 11.39 6.24

BRIEF-Advisory Board Co Q1 adjusted earnings per share $0.47

* Sees 2017 adjusted revenue guidance $780.0 million - $840.0 million

May 04 2017

BRIEF-Advisory Board Q1 adjusted earnings per share $0.47

* Advisory Board Co- sees 2017 adjusted revenue guidance $ 780.0 million- 840.0 million

May 04 2017

Exclusive: Evolent Health explores merger with Advisory Board - sources

Healthcare technology provider Evolent Health Inc is exploring a potential combination with Advisory Board Co , the business consulting company targeted by activist fund Elliott Management, people familiar with the matter said.

Mar 24 2017

BRIEF-Elliott Associates reports 8.3 pct stake in Advisory Board

* Elliott Associates - collectively have combined economic exposure in Advisory Board of about 8.3 percent of common stock as of March 2 2017 - SEC filing

Mar 03 2017

BRIEF-Advisory Board Co comments on Elliott Management's filing

* Says aware of Elliott's filing and Elliott Management's investment in the Advisory Board Company

Jan 12 2017

Elliott discloses 8.3 pct stake in Advisory Board

Jan 12 Elliott Associates LP, a unit of activist hedge fund Elliott Management Corp, disclosed an 8.3 percent stake in healthcare technology provider Advisory Board Co , saying the company's stock was "significantly undervalued".

Jan 12 2017

More From Around the Web

Earnings vs. Estimates